Imprimis Pharma (IMMY) Reports Q3 Loss of $0.29/Share

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. ANET
7. SWKS
8. CVS
9. SPY
10. XYZ

Go back to Imprimis Pharma (IMMY) Reports Q3 Loss of $0.29/Share

Imprimis Pharmaceuticals Announces Third Quarter 2016 Financial Results

November 14, 2016 4:05 PM EST

SAN DIEGO, Nov. 14, 2016 /PRNewswire/ -- Imprimis Pharmaceuticals, Inc. (NASDAQ: IMMY), a pharmaceutical company focused on the production and dispensing of high quality innovative compounded medications, today reported financial results for the third quarter 2016.

Recent Highlights:

Revenue of $4.9 million in the third quarter of 2016, up 81% compared to revenue of $2.7 million reported in the same quarter a year ago... More